Literature DB >> 33999289

IgA nephropathy with serum ANCA positivity: case series and literature review.

Gabriel Ștefan1,2, George Terinte-Balcan3, Simona Stancu4,5, Adrian Zugravu4,5, Mihaela Gherghiceanu6,3, Gabriel Mircescu4,5.   

Abstract

The co-occurrence of IgA nephropathy (IgAN) and positive anti-neutrophil cytoplasmic autoantibodies (ANCA) serology is uncommon. In the present case series and literature review, we aimed to clarify the impact of ANCA on pathogenesis, clinical and histopathology presentation, and outcome in IgAN patients. We report four patients with an overlap lesion of IgAN-ANCA positive. Also, we performed a narrative review of all biopsy-proven published case series. Only 1.2% patients had ANCA in our 330-biopsy-proven IgAN cohort. We compared our data with previous reports-6 case series and 3 small retrospective studies-a total of 103 patients. All patients but one had eGFR below 15 mL/min at diagnosis. Besides rapidly decreasing eGFR, all presented with proteinuria around 1.5 g/day and dysmorphic microhematuria, suggesting glomerular inflammation. Systemic symptoms suggestive for ANCA vasculitis were seen in half of our patients, but only one patient had hemorrhagic alveolitis. Patients from our cohort responded to the intensive immunosuppressive regimens used in ANCA-positive vasculitis with renal involvement. However, in the follow-up, one patient had a relapse followed by septic shock related to immunosuppression and one patient started hemodialysis. In the review, we found that IgAN-ANCA -positive patients are characterized by vasculitis-like lesions and clinically by a rapidly progressive decline in kidney function, which was reversed by an aggressive induction immunosuppressive protocol used in ANCA vasculitis. Checking ANCA serology seems useful in patients with rapidly progressive IgAN for therapeutic and prognostic reasons.

Entities:  

Keywords:  ANCA vasculitis; Crescents; IgA nephropathy; Rapidly progressive

Mesh:

Substances:

Year:  2021        PMID: 33999289     DOI: 10.1007/s00296-021-04888-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  17 in total

1.  Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN.

Authors:  Sanjeev Sethi; Mark Haas; Glen S Markowitz; Vivette D D'Agati; Helmut G Rennke; J Charles Jennette; Ingeborg M Bajema; Charles E Alpers; Anthony Chang; Lynn D Cornell; Fernando G Cosio; Agnes B Fogo; Richard J Glassock; Sundaram Hariharan; Neeraja Kambham; Donna J Lager; Nelson Leung; Michael Mengel; Karl A Nath; Ian S Roberts; Brad H Rovin; Surya V Seshan; Richard J H Smith; Patrick D Walker; Christopher G Winearls; Gerald B Appel; Mariam P Alexander; Daniel C Cattran; Carmen Avila Casado; H Terence Cook; An S De Vriese; Jai Radhakrishnan; Lorraine C Racusen; Pierre Ronco; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

2.  Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression.

Authors:  E Allmaras; R Nowack; K Andrassy; R Waldherr; F van der Woude; E Ritz
Journal:  Clin Nephrol       Date:  1997-11       Impact factor: 0.975

Review 3.  Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors.

Authors:  Armen Yuri Gasparyan; Lilit Ayvazyan; Heather Blackmore; George D Kitas
Journal:  Rheumatol Int       Date:  2011-07-29       Impact factor: 2.631

4.  Clinical value of systemic symptoms in IgA nephropathy with ANCA positivity.

Authors:  Lijiao Xie; Jianghua He; Xing Liu; Sha Tang; Weili Wang; Furong Li; Ying Zhang; Jun Zhang; Yunjian Huang; Jinghong Zhao; Yafei Li; Jingbo Zhang
Journal:  Clin Rheumatol       Date:  2017-12-04       Impact factor: 2.980

Review 5.  Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features.

Authors:  J Savige; D Davies; R J Falk; J C Jennette; A Wiik
Journal:  Kidney Int       Date:  2000-03       Impact factor: 10.612

6.  ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.

Authors:  M Haas; J Jafri; S M Bartosh; S L Karp; S G Adler; S M Meehan
Journal:  Am J Kidney Dis       Date:  2000-10       Impact factor: 8.860

Review 7.  IgA nephropathy.

Authors:  Kar Neng Lai; Sydney C W Tang; Francesco Paolo Schena; Jan Novak; Yasuhiko Tomino; Agnes B Fogo; Richard J Glassock
Journal:  Nat Rev Dis Primers       Date:  2016-02-11       Impact factor: 52.329

8.  Antineutrophil cytoplasmic antibodies in IgA nephropathy and Henoch-Schönlein purpura.

Authors:  D J O'Donoghue; P Nusbaum; L H Noel; L Halbwachs-Mecarelli; P Lesavre
Journal:  Nephrol Dial Transplant       Date:  1992       Impact factor: 5.992

9.  Rapidly progressive IgA nephropathy: a form of vasculitis or a complement-mediated disease?

Authors:  Jorge Rojas-Rivera; Gema Fernández-Juárez; Manuel Praga
Journal:  Clin Kidney J       Date:  2015-09-24

10.  Clinical features of IgA nephropathy with serum ANCA positivity: a retrospective case-control study.

Authors:  Ya-Zi Yang; Su-Fang Shi; Yu-Qing Chen; Min Chen; Yi-He Yang; Xin-Fang Xie; Rong Zou; Ji-Cheng Lv; Li-Jun Liu; Hong Zhang
Journal:  Clin Kidney J       Date:  2015-08-30
View more
  2 in total

1.  Coexistence of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and IgA nephropathy.

Authors:  Yong Zhong; Xiangcheng Xiao; Qi Xiong; Wei Lin; Chanjuan Shen; Ting Meng; Rong Tang; Joshua D Ooi; Peter J Eggenhuizen; Jinbiao Chen; Wannian Nie; Xia Li; Qiaoling Zhou; Ping Xiao
Journal:  Immunol Res       Date:  2022-10-13       Impact factor: 4.505

2.  Glomerular IgA Deposition and Serum Antineutrophil Cytoplasmic Antibody Positivity in a Child With Dystrophic Epidermolysis Bullosa: Case Report and Literature Review.

Authors:  Ling Yu; Guoping Huang; Zhihong Lu; Jingjing Wang; Weizhong Gu; Junping Li; Jianhua Mao
Journal:  Front Pediatr       Date:  2022-07-11       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.